Exome Asset Management

Description

Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare.

Exome Asset Management is a New York-based healthcare-focused hedge fund managing approximately $549M in public-market equities across pharmaceuticals, biotechnology, medical devices, and healthcare services; it does not acquire or invest in private dental or healthcare-services platforms.

Exome Asset Management is a public-markets hedge fund (~$549M AUM) investing in listed healthcare equities (pharma, biotech, medical devices, healthcare services) — it is a securities asset manager, not a buyer or platform acquirer of private healthcare or dental practices.

enriched 2026-05-05

Financials